EZH2 Inhibition Enhances PD‐L1 Protein Stability Through USP22‐Mediated Deubiquitination in Colorectal Cancer.

MLA

Huang, Jiaqi, et al. “EZH2 Inhibition Enhances PD‐L1 Protein Stability Through USP22‐Mediated Deubiquitination in Colorectal Cancer.” Advanced Science, vol. 11, no. 23, June 2024, pp. 1–18. EBSCOhost, https://doi.org/10.1002/advs.202308045.

APA

Huang, J., Yin, Q., Wang, Y., Zhou, X., Guo, Y., Tang, Y., Cheng, R., Yu, X., Zhang, J., Huang, C., Huang, Z., Zhang, J., Guo, Z., Huo, X., Sun, Y., Li, Y., Wang, H., Yang, J., & Xue, L. (2024). EZH2 Inhibition Enhances PD‐L1 Protein Stability Through USP22‐Mediated Deubiquitination in Colorectal Cancer. Advanced Science, 11(23), 1–18. https://doi.org/10.1002/advs.202308045

Chicago

Huang, Jiaqi, Qianqian Yin, Yuqing Wang, Xin Zhou, Yunyun Guo, Yuanjun Tang, Rui Cheng, et al. 2024. “EZH2 Inhibition Enhances PD‐L1 Protein Stability Through USP22‐Mediated Deubiquitination in Colorectal Cancer.” Advanced Science 11 (23): 1–18. doi:10.1002/advs.202308045.